' INTRODUCTION
The family of ethylene cross-bridged tetraamine macrocyclic ligands ( Figure 1a ) has become valuable as metal chelators in coordination, catalytic, as well as medicinal chemistry.
1,2 Their pendant-armed derivatives have been especially useful in endowing corresponding metal complexes with remarkable kinetic inertness. One lead bifunctional chelator for copper radiometals has been the bis-carboxymethyl pendant-armed cross-bridged cyclam, CB-TE2A (Figure 1b) . Its 64 Cu-labeled bioconjugates have significantly improved in vivo behavior and superior inertness toward radiometal loss and are of interest for positron emission tomography (PET) imaging applications. 2, 3 We have been developing a second generation of cross-bridged ligands aimed at improving the kinetics of complexation and decreasing nontarget organ accumulation. 4 Springborg and co-workers previously reported an interesting series of trimethylene cross-bridged tetraazamacrocycles and their coordination chemistry (Figure 1c, 1d) . 1, 5 A limited number of pendant-armed derivatives of these ligands have been investigated, though none with ionizable functional groups. 6, 7 We were intrigued whether such a trimethylene crossbridged tetraamine derivative would have distinct in vitro or in vivo behavior compared to its most closely related ethylene cross-bridged analogues. We report here the synthesis and characterization of a dicarboxymethyl pendant-armed cyclen with such a cross-bridge, C3B-DO2A (1), as well as its isomeric ethylene cross-bridged homocyclen ligand, CB-TR2A (2) (Figure 2 ). Their copper(II) complexes have been prepared and fully characterized. Finally, 64 Cu radiolabeling and animal biodistribution studies have been carried out for comparison with each other, and with the widely used chelator CB-TE2A, with the overall goal of developing the optimal 64 Cu-cross-bridged complex for conjugation to biomolecules as potential PET imaging agents.
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' RESULTS AND DISCUSSION Synthesis. The ligand C3B-DO2A (1) was synthesized by N-alkylation of the parent trimethylene cross-bridged Springborg ligand (3, C3B-cyclen) 6 with t-butyl bromoacetate (Scheme 1) to give diester 4 as a hydrobromide salt. Deprotection of this product with excess trifluoroacetic acid (TFA) provided H 2 -C3B-DO2A, also as a hydrobromide (H 2 -1 3 HBr). The synthetic route used for preparation of CB-TR2A (2) is shown in Scheme 2. The approach from homocyclen to crossbridged homocyclen has been communicated previously, 8 but we include synthetic details and characterization data herein.
Condensation of homocyclen with aqueous glyoxal in MeCN leads to a mixture of two constitutionally isomeric cis-fused tetracyclic bisaminals, 5 (major) and 6 (minor), which were separated chromatographically. 9 The major isomer (5), the desired compound, was shown to be cis-fused by virtue of dynamic NMR spectra indicative of enantiomerization (selected variable temperature 13 C{ 1 H} NMR spectral data are included in the experimental details for compound 5).
9,10 Highly regio-and stereoselective dibenzylation of 5 gives rac salt 7 through benzylation on the most sterically available nitrogen lone pairs. Double reductive ring expansion with NaBH 4 gives dibenzyl cross-bridged homocyclen 8, which is debenzylated to cross-bridged homocyclen 9 by hydrogenolysis. In analogy to our synthesis of CB-TE2A 3 and C3B-DO2A (1) (vide supra), 9 was di-N-alkylated with t-butyl bromoacetate to give bis-ester-armed derivative 10, which was deprotected with TFA to give the desired ligand as H 2 -CB-TR2A (H 2 -2) as a TFA salt. Electrochemical and Acid Inertness Studies. Cyclic voltammetry of Cu-C3B-DO2A (11) in 0.1 N sodium acetate revealed an irreversible reduction wave with a peak potential at -1.05 V (Ag/AgCl, scan rate 200 mV/s) with a large copper stripping peak in the return scan. Under the same conditions, Cu-CB-TR2A (12) exhibited a quasi-reversible reduction wave at -0.95 V with a peak-to-peak separation of 138 mV. Our previous results indicated that Cu(II)-complexes of ethylene cross-bridged cyclam and its derivatives typically have quasi-reversible reductions while cyclen analogues display irreversible reductions. 11, 12 Thus, electrochemically Cu-C3B-DO2A (11) behaves as expected for a cross-bridged cyclen complex while the isomeric homocyclenbased complex Cu-CB-TR2A (12) is more similar to crossbridged cyclam complexes. The possible relevance of Cu(II) reduction potentials to in vivo radio-copper loss from tetraazamacrocyclic chelators and their bioconjugates has been postulated. 12 It was hypothesized that Cu(II) reduction potentials lower than about -0.6 V (Ag/AgCl) may be necessary to avoid reduction by common bioreductants. If indeed so, neither of these complexes should be susceptible to in vivo Cu(II) reduction.
Acid inertness data of Cu(II)-tetraamine complexes provide a convenient measure of their resistance toward demetalation in aqueous solution. We have found acid inertness half-lives obtained under pseudo first-order conditions to be useful first predictors for in vivo viability of 64 Cu-labeled chelator complexes. 2 In particular, Cu-CB-TE2A was shown to have a half-life of more than 6 d even in 5 M HCl at 90°C.
11 Studies in 5 M HCl solutions at 30°C revealed that Cu-C3B-DO2A (11) is indefinitely inert while Cu-CB-TR2A (12) dissociated with a half-life of 10.8(4) h. Remarkably, the Cu-C3B-DO2A (11) complex only demetalated in 12 M HCl at 90°C with a half-life of 1.1(1) d. To our knowledge, this represents the most acid-inert copper amine complex studied. Since Springborg reported the half-life of the parent trimethylene cross-bridged copper complex in 5 M HCl at 25°C to be almost 6 days while we have found the isomeric Cu-CB-homocyclen complex to be significantly less inert (half-life only 4.8 h in 1 M HCl, 30°C), 5, 13 the trimethylene bridge does appear to impart greater acid inertness. Here, Inorganic Chemistry ARTICLE attachment of the two enveloping carboxymethyl pendant arms further enhanced the acid inertness of Cu-C3B-DO2A (11) even beyond that of Cu-CB-TE2A.
X-ray Structural Data. A summary of crystal data for the two X-ray diffraction studies can be found in Table 1 . While the quality of the Cu-CB-TR2A (12) crystal used was relatively poor, nonetheless three distinct six-coordinated distorted octahedral complexes with N 4 O 2 coordination spheres were found. Each of these provides a pendant arm oxygen to bridge two of three sodium cations which together form a central core for this assembly. Two of these, complexes 12A and 12B are well-defined ( Figure 3 Inorganic Chemistry
The X-ray structure of Cu-C3B-DO2A (11) is shown in Figure 4 . Its good metal-ligand fit is indicated by observed internal "axial" and "equatorial" N-Cu-N angles of 173.6(1)°a nd 97.5(1)°respectively. Similar numbers were found in a Cu(II) complex of the parent trimethylene cross-bridged cyclen (170.5°and 99.0°). 5 The first angle indicates that the cation is protruding slightly from the ligand cavity while the latter value is substantially larger than those found in reported ethylene crossbridged ligand Cu(II) complexes (typically around 80°) as a result of its trimethylene cross-bridging. 14, 15 Its Jahn-Teller elongation is along the N(1)-Cu(1)-O(3) axis which deviates substantially from linearity at 159°. The copper-nitrogen bond distances range from 2.0 to 2.2 Å, similar to those found in Cu-CB-TR2A (12), while the Cu-O distances are 2.00 and 2.45 Å. In light of these observations, no significant structural insight can be gleaned to account for the very disparate acid inertness between these two complexes.
Radiochemistry. Consistent with the extremely high acid inertness of its Cu-complex, radiolabeling of C3B-DO2A was found to be very challenging and ultimately required rather harsh conditions for successful labeling. Radiolabeling was attempted under a variety of aqueous conditions, varying concentration (0.5-1 μg/μL), buffer (0.1-1.25 M NH 4 OAc, 0.1-0.5 M NH 4 -citrate, and 0.1-0.5 Na 2 HPO 4 ), pH (4.5-8), and temperature (25-95°C). Reactions were monitored over time to assess the rate of complexation. All reactions had very disappointing yields that rarely exceeded 50% within 2 h, even at high temperature. At longer time points (3-18 h) the yields were generally better; however, they rarely were >70%. Furthermore, instability of the 64 Cu-C3B-DO2A complex was observed in the form of secondary peak formation. Although in our hands, radiolysis has not been commonly observed for small molecules, reactions were carried out in the presence of two different radiolytic scavengers (12) and Cu-C3B-DO2A (11)
Inorganic Chemistry ARTICLE with no significant benefit. Carrier-added reactions did not improve radiolabeling yields. After many failed attempts at radiolabeling 1 with high yields under aqueous conditions, the standard conditions for radiolabeling CB-TE2A were attempted, 16 by dissolving the compound (0.5-3 mg) in ethanol (50-100 mL), preincubating it in the presence of an excess of Cs 2 CO 3 and then heating the reaction at 95°C with 100-130 μCi of 64 Cu. Unfortunately, the yields were still relatively low (30-70% after 1 h) and did not exceed 85% even after several hours. Replacing Cs 2 CO 3 with Li 2 CO 3 resulted in extremely low yields (3-6%) at all time points (1-18 h). Again, carrier-added reactions did not generate any improvement in radiolabeling yield.
In an attempt to speed up the reaction kinetics, a microwave reactor was employed. In all reactions 1.0 μg C3B-DO2A was incubated with ∼100 μCi 64 Cu in a total volume of 300 μL. Many different reactions were performed where solvent, pH, temperature, and reaction time were varied, and it was found that the shortest reaction that consistently provided a greater than 97% radiochemical purity consisted of microwave heating a solution of 1 in Milli-Q water at pH = 3 to 100°C for 2 h.
In contrast, CB-TR2A was successfully labeled with 64 Cu by the method employed for CB-TE2A 16 (radiochemical purity g98%) at room temperature in basic ethanolic solution. A single peak corresponding to 64 Cu-CB-TR2A was confirmed by radio-TLC. Biodistribution Studies. The biodistribution of 64 Cu-C3B-DO2A and 64 Cu-CB-TR2A were determined in normal, juvenile
Lewis rats to examine their in vivo properties. The blood, liver, and kidney clearance of these agents are plotted in Figure 5 Cu-CB-TR2A may be attributed to hepatobilary clearance, transchelation of copper to liver proteins is also a likely possibility. 17 Boswell et al. reported the transchelation of radiocopper to liver proteins such as superoxide dismutase and metallotheinein after injection of 64 Cu labeled CB-chelators. 18 At this time it is unclear why CB-TR2A was less stable in vivo than CB-DO2A despite its comparatively low reduction potential and its relative kinetic acid inertness. 64 Cu-C3B-DO2A exhibited very slow clearance from the liver compared to CB-TR2A, CB-DO2A, and CB-TE2A (percent reduction at 22 or 24 h PI: 22. Cu-C3B-DO2A observed here suggests significant radiometal loss in the liver from what was predicted to be a very inert complex. Close examination of the X-ray structure of Cu-C3B-DO2A revealed that the trimethylene cross-bridge led to a larger equatorial NCu-N angle of 98°instead of the 80-88°typical for its ethylene-bridged analogues but no other noteworthy differences in Cu-chelator bonding parameters. The possibility that an incompletely formed, perhaps out-of-cavity, 64 Cu complex being the actual radiolabeled product can account for the observed radiocopper loss in vivo. However, the very harsh radiolabeling conditions (2 h, microwave 100°C, pH 3) mitigate against such a kinetic product. Other contributing factors affecting in vivo clearance including lipophilicity, susceptibility to metabolic degradation, or formation of easily reduced ternary complexes as a consequence of this trimethylene cross-bridge may be implicated but will require additional SAR studies for validation. 19 
' SUMMARY
The trimethylene cross-bridged chelator C3B-DO2A (1) and its ethylene cross-bridged isomer CB-TR2A (2) have been 13 C{ 1 H} NMR spectra of 5 were acquired on a JEOL FX-90Q spectrometer operating at 22.5 MHz. IR spectra were recorded using KBr pellets on a Nicolet MX-1 FT-IR Spectrophotometer. ESI-MS was performed on a Thermofinnigan LCQ Mass Spectrometer coupled to a Picoview electrospray source or on a Waters Micromass ZQ 4000. FAB-MS data were acquired on the JEOL JMS-AX505HA Mass Spectrometer at the University of Notre Dame. Electronic spectra were measured using a Cary 219 spectrophotometer. Elemental analyses were performed at Atlantic Microlab Inc. Norcross, GA.
All solvents were reagent grade and from commercial sources and were used without further purification. All metal complexation reactions were performed in standard Schlenk glassware under a nitrogen atmosphere. Recrystallizations were conducted in closed containers without precautions to exclude either air or moisture. Bulk solvent removal was by rotary evaporation under reduced pressure, and trace solvent removal from solids was by vacuum pump evacuation.
Caution! Perchlorate salts of metal complexes containing organic ligands as solids or in organic solvents are potentially explosive. Although no problems were encountered by us, cautious handling of only small amounts of these compounds should be the rule.
Ligand Synthesis. C3B-cyclen (3) was synthesized according to a procedure previously published by Springborg et al. in 1995. 20 Briefly, cyclen (1,4,7,10-tetraazacyclododecane) was treated with 2 equiv of ptoluenesulfonyl chloride (TsCl) in pyridine: the only product obtained was cyclen-1,7-bis-p-toluenesulfonamide. The 3-carbon cross bridge was then introduced by alkylation of the 2 secondary nitrogens with 1 equiv of 1,3-propanediol di-p-toluenesulfonate. The N-protecting tosyl groups were removed from the crude product in refluxing HBr/CH 3 COOH (3 days), and the crude product was recrystallized to give pure 3 3 3HBr.
4,10-Bis-(carbo-tert-butoxymethyl)-1,4,7,10-tetraazabicyclo[5.5.3]pentadecane Hydrobromide (4 3 HBr).
The compound C3B-cyclen 3 3HBr (3 3 3HBr, 0.45 g, 0.99 mmol) was dissolved in MeCN (25 mL). Na 2 CO 3 (0.45 g, 4.2 mmol) and tert-butyl bromoacetate (0.34 mL, 2.3 mmol) were then added, and the reaction was heated to 60°C for 3 days. After cooling, solids were removed by filtration, and the filtrate was evaporated under reduced pressure. Residual solvent was removed under high vacuum, and the product was triturated with diethyl ether to give 4 3 HBr (0.42 g) in 81% yield as the residual solid. This material was taken on without further purification. 1 (8) . NaBH 4 (13.10 g, 0.340 mol) was added in small portions over 20 min to a stirred solution of dibenzyl tetracyclic bisaminal dibromide salt 7 (3.05 g, 5.55 mmol) in 95% EtOH (75 mL). The reaction mixture was stirred at room temperature for 10 days. Excess NaBH 4 was then decomposed by slow addition of 150 mL 3 M HCl. Evaporation of solvent under reduced pressure gave a white solid which was dissolved in H 2 O (100 mL), adjusted to pH 14 with solid KOH (with cooling), and extracted with benzene (6 Â 50 mL). The combined extracts were dried (Na 2 SO 4 ), and solvent was removed under reduced pressure to yield 1.44 g (quant) of product as a viscous oil; (9) . Hydrogenolysis of 8 was carried out in a glass apparatus designed for the exclusion of O 2 and for measurement of H 2 uptake with maintenance of constant pressure. 10% Pd/C (0.20 g) and glacial HOAc (60 mL) were added to a 125 mL hydrogenation flask which was connected to the apparatus. The system was evacuated (water aspirator) and flushed with nitrogen four times. The system was then evacuated, filled with hydrogen, and catalyst was equilibrated under H 2 (767 mmHg) for 1.5 h. To this was added a solution of 8 (1.11 g, 2.83 mmol) in glacial HOAc (5 mL). The mixture was stirred for 19 h under H 2 (767 mmHg). (The theoretical H 2 uptake for this reaction was 138 mL. The observed uptake was 144 mL.) The apparatus was then evacuated and flushed with nitrogen four times, the reaction flask was removed from the apparatus, the contents were filtered through Celite, and the catalyst and Celite were washed with glacial HOAc (2 Â 5 mL). The combined filtrate and washings were concentrated under reduced pressure to give a light yellow oil which was dissolved in H 2 O (50 mL), adjusted to pH 14 with KOH, and extracted with benzene (5 Â 50 mL). The combined extracts were dried (Na 2 SO 4 ), and solvent was removed under reduced pressure to give an oil. After kugelrohr distillation (90-120°C air bath temperature, 0.03 mmHg), the product oil solidified upon standing to give 0.494 g (82% crude yield) of solid product. This material contained minor impurities and was therefore further purified. The solid was dissolved in absolute EtOH (5 mL) containing conc HCl (1 mL). A hydrochloride salt crystallized, was filtered, washed with cold (0-5°C) absolute EtOH (2 Â 1 mL), and air-dried. This solid was dissolved in H 2 O (10 mL), adjusted to pH 14 with solid KOH (with cooling), and extracted with benzene (6 Â 15 mL). The combined extracts were dried (Na 2 SO 4 ), and solvent was removed under reduced pressure to give an oil. This oil was kugelrohr distilled (100°C air bath temperature, 0.03 mmHg) and subsequently solidified upon standing to give 0.283 g (47%) of pure product as a white solid: mp 28-30°C; ); Cyclic voltammetry conducted in 0.1 sodium acetate: indicated a quasi-reversible reduction with E F = -0.950 V (Ag/AgCl). A 0.13 M solution of Cu-CB-TR2A 3 2 (H 2 O) 3 1.2(NaClO 4 ) in 95% EtOH was placed in a diethylether diffusion chamber. Plate-like blue crystals were collected for X-ray structural analysis, which yielded an empirical formula of Cu-CB-TR2A 3 H 2 O 3 NaClO 4 .
X-ray Crystallography. Cu-CB-TR2A (11) . A blue plate crystal was mounted in a Nylon loop, and X-ray diffraction data collected on a Bruker D8 diffractometer equipped with an APEX CCD detector at 173 K. The monoclinic space group P2 1 /c was uniquely assigned from systematic absences. The structure was solved by direct methods. Except as noted, non-hydrogen atoms were refined with anisotropic thermal parameters, and hydrogen atoms were included as idealized contributions. The structure was found to be extensively disordered with regard to both the macrocycle and the counterions. Satisfactory disorder models could be created for both, but extensive restraint was necessary because of limited resolution in the diffraction data. The perchlorate ions were refined as rigid tetrahedra, and several carbon atoms in the heterocycle were refined with isotropic thermal parameters. Additionally, the thermal parameters for C37 and its disorder partner, C37a were refined with the EADP command.
Cu-C3B-DO2A (12) . A blue rod 0.15 Â 0.10 Â 0.10 mm in size was mounted on a Cryoloop with Paratone oil. Data were collected in a nitrogen gas stream at 100(2) K using j and ω scans. Crystal-todetector distance was 60 mm and exposure time was 10 s per frame using a scan width of 0.5°. Data collection was 99.9% complete to 67.00°in q. A total of 26635 reflections were collected covering the indices, -14 e h e 14, -16 e k e 16, -21 e l e 16. A total of 5166 reflections were found to be symmetry independent, with an R int of 0.0299. Indexing and unit cell refinement indicated a primitive, monoclinic lattice. The space group was found to be P2(1)/n (No. 14). The data were integrated using the Bruker SAINT software program and scaled using the SADABS software program. Solution by direct methods (SIR-97) produced a complete heavy-atom phasing model consistent with the proposed structure. All non-hydrogen atoms were refined anisotropically by fullmatrix least-squares (SHELXL-97). All hydrogen atoms were placed using a riding model. Their positions were constrained relative to their parent atom using the appropriate HFIX command in SHELXL-97.
Radiochemistry. The highest radiochemical purity with greatest consistency of yield was obtained using a microwave assisted reaction. A solution of 64 CuCl 2 (750 μCi in 50 μL Milli-Q water, pH 3) was added to 4.61 μg (14.0 nmol) C3B-DO2A dissolved in 250 μL of Milli-Q water (pH 3). The sealed vial containing the reaction mixture was placed in the microwave reactor, stirred for 2 min, and then heated at 100°C for 2 h. Complex formation was confirmed by radio-TLC (Rf ∼ 0.8, C18 silica plates, eluent: methanol/10% ammonium acetate 7:3, Rf ( 64 Cu-acetate = 0). Radiochemical purity was determined by HPLC and found to be g98% before use in animal studies (Complex retention time 10.55 min; Agilent C8 column; isocratic, 0.1% TFA in water; 0.5 mL/min).
Biodistribution Studies. Animal experiments were carried out in compliance with the Guidelines for the Care and Use of Research Animals established by Washington University's Animal Studies Committee. Tissue distribution studies were performed in male Lewis rats (34-42 day old) after intravenous injection of the radiolabeled compound, 64 Cu-C3B-DO2A (45 μCi; 0.9 nmol ligand) and 64 Cu-CB-TR2A (100 μCi) via the tail vein (100-150 μL). Tissue biodistribution data were obtained at 1, 4, and 24 h post injection (PI). Animals were sacrificed at the appropriate time points, organs of interest were removed and weighed, and the radioactivity was measured in a gamma counter. The percent injected dose per gram (%ID/g) and percent injected dose per organ (%ID/organ) were calculated by comparison to a weighed and counted standard. Rats were allowed food and water ad libitum. Animals in the 24 h group for 64 Cu-C3B-DO2A and 64
Cu-NOTA were maintained in metabolism cages; urine and feces were collected.
All biodistribution data are presented as the mean ( standard deviation. Group comparisons were made using standard ANOVA methods. Post hoc testing of individual group differences was accomplished with the Bonferroni test. Groups with p < 0.05 were considered significantly different. GraphPad Prism software (version 5.02; San Diego, CA) was used for all statistical analyses.
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